Zhongguancun

SZSE · 000931

shenzhen stock exchangereal estate infrastructure
Market Cap$3.1B
Revenue$2.3B
P/E Ratio208.5
Listed OnSZSE
Ticker000931
IndustryMedical Instruments & Supplies
CEO / ExecMr. Zhanjun Hou
HeadquartersBeijing
MarketMainland China
Websitewww.centek.com.cn

Overview

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of exogenous opioids; Hydrocodone acetaminophen tablets for the treatment of moderate to severe pain; Am

Data Note

This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.